ADPT - Adaptive Biotechnologies Corp

Insider Sale by Lo Francis (Chief People Officer)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

4 days ago, Lo Francis, serving as Chief People Officer at Adaptive Biotechnologies Corp (ADPT), sold 30,593 shares at $14.08 per share, for a total transaction value of $430,749.00. Following this transaction, Lo Francis now holds 293,874 shares of ADPT.

This sale represents a 9.00% decrease in Lo Francis's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, March 11, 2026 and publicly disclosed via SEC Form 4 filing on Friday, March 13, 2026, 2 days after the trade was made.

Adaptive Biotechnologies Corp operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Lo Francis

Chief People Officer

Francis Lo is the Chief People Officer at Adaptive Biotechnologies Corporation (ADPT), a commercial-stage biotechnology company focused on translating the genetics of the adaptive immune system into clinical products for diagnosing and treating disease[[1]](https://www.adaptivebiotech.com/adaptive-leadership/francis-lo/)[[2]](https://www.adaptivebiotech.com/member_type/leadership/)[[3]](https://fintool.com/app/research/companies/ADPT/people/francis-lo). He has held this role since May 2019, bringing a multi-disciplinary perspective to leading People and Culture, with contributions to employee retention and human capital outcomes amid 42% MRD revenue growth to $145.5 million in 2024[[1]](https://www.adaptivebiotech.com/adaptive-leadership/francis-lo/)[[3]](https://fintool.com/app/research/companies/ADPT/people/francis-lo). Prior to Adaptive, Francis served as Vice President of Human Resources at Whole Foods Market (2017–2019) and held leadership positions at Starbucks, including Director of Global Talent Management and Dean of Starbucks China University[[1]](https://www.adaptivebiotech.com/adaptive-leadership/francis-lo/)[[2]](https://www.adaptivebiotech.com/member_type/leadership/)[[3]](https://fintool.com/app/research/companies/ADPT/people/francis-lo). His career also includes experience in CPG sales, strategy, consumer insights, and shopper marketing, alongside board service for non-profit organizations[[1]](https://www.adaptivebiotech.com/adaptive-leadership/francis-lo/). Francis holds an MBA from Stanford University Graduate School of Business and a BA from the University of Texas at Austin's Plan II Honors Program[[1]](https://www.adaptivebiotech.com/adaptive-leadership/francis-lo/)[[3]](https://fintool.com/app/research/companies/ADPT/people/francis-lo). As a corporate insider, he has engaged in recent stock transactions, including sales in 2025 and 2026[[4]](https://www.sahmcapital.com/news/content/chief-people-officer-francis-lo-reports-sale-of-adaptive-biotechnologies-common-shares-2026-01-07)[[5]](https://www.secform4.com/insider-trading/1780660.htm)[[6]](https://www.investing.com/news/insider-trading-news/adaptive-biotechnologies-lo-francis-sells-76895-in-shares-93CH-4436110).

View full insider profile →

Trade Price

$14.08

Quantity

30,593

Total Value

$430,749.00

Shares Owned

293,874

Trade Date

Wednesday, March 11, 2026

4 days ago

SEC Filing Date

Friday, March 13, 2026

Filed 2 days after trade

HEALTHCAREBIOTECHNOLOGY

About Adaptive Biotechnologies Corp

Company Overview

No company information available
View news mentioning ADPT

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/4758252

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime